医用聚甲醛 (POM) 市场 - 2023 年至 2028 年预测

2021年医用聚甲醛（POM）市场规模为47,912,000美元。

医用聚甲醛（通常称为 POM 或乙缩醛）是一种高性能工程热塑性塑料，用于医疗行业的各种应用。 由于其独特的性能，如高刚度、更高的尺寸稳定性和低摩擦係数，它越来越多地被製药和生物技术公司用于医疗器械製造过程。 最常用的医用聚甲醛是共聚物POM和均聚物POM。 均聚物 POM 由单一类型的单体製成，由同一分子的重复组成，因此具有高机械和热性能以及高结晶度和刚度。 相比之下，共聚物 POM 是由两种不同类型的单体製成的聚合物。 医用聚甲醛主要用于製造透析器、吸入器、医疗托盘、手术器械手柄、胰岛素笔和药物瓶盖。

由于POM是一种可回收材料，由于环保意识的提高，医疗保健行业对可持续材料的需求不断增加，医用POM的需求也在不断增加。 一些医疗器械製造商正在将回收的 POM 融入其产品中，以减少对环境的影响。 此外，医疗保健支出和基础设施的增长、医疗设备需求的增加以及高级医用 POM 生产新兴市场的开发预计将导致预测期内医用聚甲醛市场的扩张。

医疗设备和设备的需求不断增长正在推动医疗 POM 市场的增长。

POM 由于其耐化学品和生物製剂而被广泛用于製造需要经常清洁和灭菌的医疗器械。 印度品牌资产基金会预计，2021年印度医疗器械行业规模将达到120亿美元，出口额约为25.3亿美元。 此外，印度医疗器械行业预计，印度医疗器械进口额将从2021年的4470.8亿卢比增至2022年的6320亿卢比，增长41%。 医用 POM 具有高度生物相容性，因为它们不会对人体组织造成任何不良或毒性反应，并且可回收，越来越多地被医疗保健公司使用。 因此，医用 POM 支持市场增长。

产品提供

• Celanex Corporation 的 Celanex POM：塞拉尼斯公司是美国一家全球领先的化学和特种材料公司，以 Celanex 品牌生产医用聚甲醛 (POM)。 Celanex POM 是一种高性能热塑性塑料，用于各种医疗应用，其性能满足医疗公司对热塑性聚酯的要求。
• 巴斯夫的 Ultraform POM：巴斯夫是一家国际化学公司，通过其 Ultraform 产品线生产医用级聚甲醛 (POM)。 巴斯夫提供医用级 Ultraform POM，它满足 ISO 10993 等各种监管要求，是一种广泛应用于医疗应用的高性能热塑性塑料。
• 恩欣格塑料(Ensinger Plastics) 的TECAFORM POM：恩欣格塑料(Ensinger Plastics) 是一家德国公司，生产各种高性能工程塑料，包括医用聚甲醛，其中包括具有增强茎桿灭菌抗性的TECAFORM POM。马苏。 该公司还为医疗行业客户提供技术支持和专业知识，以优化 Tecaform POM 在其产品中的使用，包括材料选择、设计优化和产品开发。

在医用聚甲醛市场中，按类型划分，共聚物 POM 预计将占据较大份额。

由于存在环氧乙烷等第二单体，共聚物 POM 的结晶度比均聚物 POM 低，并且具有更高的衝击强度，以及增强的耐化学性和高温耐久性。 因此，共聚物 POM 的有益特性有望增加其在医用 POM 市场中的份额。

从应用来看，对胰岛素笔的需求不断增长预计将在预测期内扩大医用 POM 市场。

周围糖尿病患者数量的不断增加以及对胰岛素笔作为有效的糖尿病护理和治疗选择的需求不断增加，正在推动对医用 POM 的需求。 例如，国际糖尿病联合会估计，过去10年，全球糖尿病的年患病率为3%。 此外，预计全球糖尿病患者总数将从 2021 年的 5.365 亿增加到 2045 年的 7.832 亿。 由于糖尿病患者人数的增加，胰岛素笔的使用也在增加。 医用级 POM 通常用于胰岛素笔製造，因为它具有独特的性能，可以承受频繁使用和其他处理步骤。 此外，医用 POM 即使暴露在不同的温度和压力下也能保持其形状，确保笔的正常功能并防止胰岛素盒洩漏或损坏。

北美对医用聚甲醛市场贡献显着，预计在预测期内将大幅增长。

该地区是製造医疗设备的国际医疗和製药公司的所在地，不断增长的消费者医疗保健支出正在推动该地区的医疗 POM 市场。 例如，美国医学会估计，2021年美国医疗保健支出将达到42551亿美元。 此外，由于患者肾功能衰竭的增加，对透析机的需求不断增长，预计将增加医用 POM 的消耗量。 美国肾臟基金会估计，大约有 570,000 名患者使用透析机，肾衰竭发生率的上升将增加对透析机的需求。

内容

第一章简介

• 市场概览
• 市场定义
• 调查范围
• 市场细分
• 货币
• 先决条件
• 基准年和预测年的时间表

第二章研究方法

• 调查数据
• 调查过程

第 3 章执行摘要

• 研究亮点

第 4 章市场动态

• 市场驱动因素
• 市场製约因素
• 波特五力分析
• 行业价值链分析

第 5 章医用聚甲醛 (POM) 市场：按类型

• 共聚物 POM
• 均聚物 POM

第 6 章医用聚甲醛 (POM) 市场：按应用分类

• 简介
• 透析器
• 吸入器
• 医疗托盘
• 手术器械手柄
• 胰岛素笔
• 药品封盖
• 其他

第七章医用聚甲醛 (POM) 市场：按地区

• 简介
• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他
• 中东/非洲
  • 沙特阿拉伯
  • 阿拉伯联合酋长国
  • 以色列
  • 其他
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 印度尼西亚
  • 泰国
  • 台湾
  • 其他

第8章竞争环境与分析

• 主要公司及战略分析
• 新兴公司和市场盈利能力
• 合併、收购、协议和合作
• 供应商竞争力矩阵

第9章公司简介

• Celanese Corporation
• BASF
• Daicel Corporation
• DuPont de Nemours, Inc.
• Ensinger Plastics
• Polyplastics Global
• Kolon Plastic Inc.
• Barlog Plastics GmbH
• SABIC
• Asahi Kasei Corporation

The medical polyoxymethylene (POM) market was valued at US$47.912 million in 2021.

Medical polyoxymethylene, commonly called POM or acetal, is a high-performance engineering thermoplastic used in the medical industry for various applications. Its unique properties, including high stiffness, enhanced dimensional stability, and low friction coefficient, is increasing its consumption by pharmaceutical and biotechnological companies for medical device manufacturing processes. Copolymer POM and homopolymer POM are the most used types of medical polyoxymethylene. Homopolymer POM is made from a single type of monomer that consists of repetitions of the same molecule resulting in a high degree of crystallinity and stiffness in addition to its high mechanical and thermal properties. In contrast, copolymer POM is a polymer made from two different types of monomers. Medical polyoxymethylene is dominantly consumed for manufacturing dialysis machines, inhalers, medical trays, handles for surgical instruments, insulin pens, and pharmaceutical closures.

The growing demand for sustainable materials in the healthcare industry, driven by the awareness of environmental issues, is creating a high demand for medical POM since POM is a recyclable material. Several healthcare equipment manufacturers are incorporating recycled POM into their products to reduce their environmental footprint. Further, the growth in healthcare expenditure and infrastructure, the rise in demand for medical devices, and the developments in the production of advanced grades of medical POM are anticipated to result in the expansion of the medical polyoxymethylene market over the forecast period.

The rise in medical devices and equipment demand is propelling the medical POM market growth.

POM is extensively used to manufacture medical devices that require frequent cleaning and sterilization due to its ability to resist chemical and biological agents. The Indian Brand Equity Foundation estimated that the Indian medical devices sector reached US$12 billion in 2021, with approximately US$2.53 billion worth of exports. Further, the Indian Medical Devices Industry estimated that the number of medical device imports in India increased by 41% to increase from Rs.44,708 crore in 2021 to Rs.63,200 crore in 2022. The biocompatibility of medical POM, since it does not cause harmful or toxic reactions to human tissue and its recyclability, is increasing its consumption by healthcare companies. Therefore, the rising consumption of medical instruments and equipment in most of the world driven by the pandemic and the general rise in the consumption of healthcare facilities by consumers is driving the growth of the medical POM market.

Product Offerings:

• Celanex POM by Celanese Corporation - Celanese Corporation is a leading global chemical and specialty materials company in the US that manufactures medical-grade polyoxymethylene (POM) under its brand, Celanex. Celanex POM is a high-performance thermoplastic used in various medical applications due to its properties to meet the requirements of thermoplastic polyester of medical companies.
• Ultraform POM by BASF -BASF is an international chemical company that produces a range of medical-grade polyoxymethylene (POM) in its Ultraform product line. BASF offers a range of medical-grade Ultraform POM grades that comply with various regulatory requirements, such as ISO 10993, and are high-performance thermoplastics widely used in medical applications.
• TECAFORM POM by Ensinger Plastics - Ensinger Plastics is a German company manufacturing various high-performance engineering plastics, including medical-grade polyoxymethylene as TECAFORM POM with enhanced steam sterilization resistance. In addition, the company provides technical support and expertise to its customers in the medical industry to optimize the use of TECAFORM POM in its products, including material selection, design optimization, and product development.

Copolymer POM is expected to hold a major share of the medical polyoxymethylene market by type.

The presence of the second monomer, such as ethylene oxide, in copolymer POM results in a lower degree of crystallinity and improved impact strength which offers enhanced chemical resistance and durability at higher temperatures than homopolymer POM. Therefore, the beneficial properties of copolymer POM are expected to increase its market share in the medical POM market.

By application, the rising demand for insulin pens is expected to expand the medical POM market over the forecast period.

The rise in the number of people diabetes patients around and the increasing demand for insulin pens as an effective diabetes care and treatment option is increasing the demand for medical POM. For instance, the International Diabetes Federation estimated that the annual prevalence rate of diabetes worldwide is 3% over the last decade. In addition, it is projected that the total number of global diabetes patients will increase from 536.5 million in 2021 to 783.2 in 2045. The rise in diabetic patients is increasing the use of insulin pens. Medical POM is commonly used in manufacturing insulin pens due to its unique properties to withstand frequent usage and other handling processes. In addition, the ability of medical POM to maintain its shape despite its exposure to different temperatures and pressures, which ensures the proper functioning of the pen and prevention of leakage or damage to the insulin cartridge, is resulting in its consumption in insulin pens.

North America contributes majorly to the medical polyoxymethylene market and is expected to grow significantly over the forecast period.

The presence of established international medical and pharmaceutical companies in the region manufacturing medical equipment and the rising healthcare expenditure by consumers is driving the medical POM market in the region. For instance, the American Medical Association estimated that the healthcare expenditure in the US in 2021 amounted to US$4,255.1 billion. Further, the growing demand for dialysis machines driven by the rise in kidney failures among patients is expected to increase the consumption of medical POM. The American Kidney Fund projected that approximately 570,000 patients are on dialysis machines and that the growth rates of kidney failures are expected to augment the demand for dialysis machines.

Market Segmentation:

By Type

• Copolymer POM
• Homopolymer POM

By Application

• Dialysis Machine
• Inhalers
• Medical Trays
• Handles for Surgical Instruments
• Insulin Pen
• Pharmaceutical Closures
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• Japan
• India
• South Korea
• Indonesia
• Thailand
• Taiwan
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Research Process

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Force Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. MEDICAL POLYOXYMETHYLENE (POM) MARKET BY TYPE

• 5.1. Copolymer POM
• 5.2. Homopolymer POM

6. MEDICAL POLYOXYMETHYLENE (POM) MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Dialysis Machine
• 6.3. Inhalers
• 6.4. Medical Trays
• 6.5. Handles for Surgical Instruments
• 6.6. Insulin Pen
• 6.7. Pharmaceutical Closures
• 6.8. Others

7. MEDICAL POLYOXYMETHYLENE (POM) MARKET BY GEOGRAPHY

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. USA
  • 7.2.2. Canada
  • 7.2.3. Mexico
• 7.3. South America
  • 7.3.1. Brazil
  • 7.3.2. Argentina
  • 7.3.3. Others
• 7.4. Europe
  • 7.4.1. Germany
  • 7.4.2. France
  • 7.4.3. United Kingdom
  • 7.4.4. Spain
  • 7.4.5. Others
• 7.5. Middle East and Africa
  • 7.5.1. Saudi Arabia
  • 7.5.2. UAE
  • 7.5.3. Israel
  • 7.5.4. Others
• 7.6. Asia Pacific
  • 7.6.1. China
  • 7.6.2. Japan
  • 7.6.3. India
  • 7.6.4. South Korea
  • 7.6.5. Indonesia
  • 7.6.6. Thailand
  • 7.6.7. Taiwan
  • 7.6.8. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Emerging Players and Market Lucrativeness
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Vendor Competitiveness Matrix

9. COMPANY PROFILES

• 9.1. Celanese Corporation
• 9.2. BASF
• 9.3. Daicel Corporation
• 9.4. DuPont de Nemours, Inc.
• 9.5. Ensinger Plastics
• 9.6. Polyplastics Global
• 9.7. Kolon Plastic Inc.
• 9.8. Barlog Plastics GmbH
• 9.9. SABIC
• 9.10. Asahi Kasei Corporation